Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tracks Real-World use of fertility drug REKOVELLE®

NCT ID NCT05499052

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 21 times

Summary

This study looked at how doctors prescribe REKOVELLE®, a fertility medicine, for women going through their first IVF or ICSI treatment. Researchers observed 201 women across clinics in Nordic countries and Switzerland to see how the drug's dosing algorithm works in everyday practice. The goal was to understand usage patterns, effectiveness, and safety, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTROLLED OVARIAN STIMULATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ferring Investigational Site

    Copenhagen, Denmark

  • Ferring Investigational Site

    Horsens, Denmark

  • Ferring Investigational Site

    Køge, Denmark

  • Ferring Investigational Site

    Odense, Denmark

  • Ferring Investigational Site

    Søborg, Denmark

  • Ferring Investigational Site

    Skien, Norway

  • Ferring Investigational Site

    Malmö, Sweden

  • Ferring Investigational Site

    Baden, Switzerland

  • Ferring Investigational Site

    Basel, Switzerland

Conditions

Explore the condition pages connected to this study.